We’re very pleased to have recently brought on Hannah Totte as our program operations associate. In addition to supporting Brenna Teigler in day-to-day operations of the program, she will put considerable energy into culling actionable insights from the many data streams that we collect as a program.
Learn how Erkan Aktakka went from a childhood selling sunflower seeds on the streets of Ankara to launching a venture that could open up new sensor applications in the Internet of Things, a $30 billion market.
Five Cyclotron Road fellows are named in the inaugural cohort for the GCxN accelerator, a collaboration between Shell’s GameChanger program and the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL). The cohort is developing long-term energy storage and control technologies for the energy grid of the future.
Activate is the event of our year, every year—it’s when our fellows get to shine and show the power of their innovations. This year’s event made Cyclotron Road co-founder and managing director Sebastien Lounis more optimistic than ever about our program and its future.
By displacing petroleum-derived material feedstocks with engineered, bio-based alternatives, Visolis is focused on creating renewable products for the circular economy. With key pieces of the puzzle now set in place, Visolis’s founder, Deepak “Sultan of Scale” Dugar, is moving the firm from pilot scale to mass production.
Our 2018 Impact Report takes a deep dive into some of the key progress indicators we're tracking and the impact we are making for our fellows. The bottom line: our support is enabling a new path for the development of an innovator and their idea that would otherwise not exist.
Antora Energy, Fervo Energy, Mosaic Materials and Visolis—four startups founded by Cyclotron Road fellows and alumni—received a total of $7.5 million in funding from a pair of Department of Energy offices as well as from the DOE’s Advanced Research Projects Agency-Energy (APRA-E) this month.
Founded by Cohort Two fellow Zachary Sun, Synvitrobio has announced an oversubscribed $2.6 million seed funding round as well as a new name—Tierra Biosciences—and the appointment of a chief scientific officer, Louis Metzger, who has a background in drug discovery at Novartis.